Increasing Minority Participation in Clinical Trials
Increasing Minority Group Participation in Clinical Trials a Randomized Controlled Study of an Office-based Educational Video
2 other identifiers
interventional
63
1 country
1
Brief Summary
This study will measure the effects of an office-based, clinical trial education video on clinical trial knowledge and enrollment in clinical trials, in a clinical sample with no previous history of clinical trial participation. This study will also determine the feasibility of implementing an office-based video educational program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 5, 2015
CompletedFirst Posted
Study publicly available on registry
November 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2017
CompletedSeptember 11, 2017
September 1, 2017
2.6 years
November 5, 2015
September 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
study feasibility
The stages of implementation completion (SIC) measure will be used as an internal tool utilized by the study team to track time to achievement of key implementation milestones. An 8-stage implementation plan to measure feasibility of the office-based educational program will be executed across 3 phases. Three scores will be derived from the SIC measure. The first score is the number of stages completed. The second score is the time spent at each stage. The third score is the proportion of activities completed at each stage. Implementation of the SIC model poses no additional burden on study participants.
12 months
Secondary Outcomes (3)
Clinical trial participation
12 months
Clinical trial knowledge survey
7-10 days
Likelihood to participate survey
7-10 days
Study Arms (2)
Standard care/control group
NO INTERVENTIONFirst, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the standard of care group will be provided standard educational resources (booklet and DVD), with no additional instructions. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.
Video viewing group
EXPERIMENTALFirst, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the video viewing group will watch the 10-minute DVD video on tablet devices using headphones in the clinic. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.
Interventions
First, participants will complete a brief electronic survey measuring their opinions on clinical trials. Next, participants in the video viewing group will watch the 10-minute DVD video on tablet devices using headphones in the clinic. Participants in this groups will be informed that a team member will call him/her in approximately 1 week to ask him/her the (same) questions about clinical research.
Eligibility Criteria
You may qualify if:
- Participants will be patients of Vanderbilt-Ingram Cancer Center (VICC) with a diagnosis of cancer Participants will have no previous history of clinical trial research participation
You may not qualify if:
- Previous history of clinical trial research participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vanderbilt University Medical Centerlead
- National Cancer Institute (NCI)collaborator
- Meharry-Vanderbilt Alliancecollaborator
Study Sites (1)
Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Consuelo H. Wilkins, MD
Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director of the Meharry-Vanderbilt Alliance, Associate Professor
Study Record Dates
First Submitted
November 5, 2015
First Posted
November 9, 2015
Study Start
December 1, 2014
Primary Completion
June 28, 2017
Study Completion
June 28, 2017
Last Updated
September 11, 2017
Record last verified: 2017-09